Press release
Autoimmune Treatment Market size is expected to grow at a CAGR of 6.9% from 2024 to 2030, reaching nearly USD 9771.2 million by 2030 as per Maximize Market Research.
Maximize Market Research, has published market intelligence and competitive landscape report on the Autoimmune Treatment Market.Over the forecast period, Autoimmune Treatment Market is expected to grow from USD 6125 Mn. to USD 9771.2 Mn. by 2030, at a CAGR of 6.9 per cent.
North America is dominating the Autoimmune Treatment Market and is expected to continue its dominance in the next 5 years, because of the high occurrence of autoimmune diseases, advanced healthcare infrastructure, and robust research and development activities.
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/198275/
North America holds the largest market share of about 39.4% of which the US has the highest incidences of autoimmune diseases, with 15 to 30 million patients affected in the analysis done in 2022. Prominent pharmaceutical firms in North America make significant investments in the creation of novel treatments for autoimmune diseases, which propels market growth.
Europe is the second largest region witnessing a notable growing adoption in the Autoimmune Treatment Market, due to the presence of key players like AbbVie, Johnson &Johnson, Eli Lilly and Company, AstraZeneca, Lupin, Amgen, Bristol-Myers Squibb, and Others, and countries like Germany, France, and UK. Europe holds a significant market share of about 28.3%, which makes it the second-largest market after North America.
The European market for autoimmune treatments is advantageous due to its well-established healthcare system, and development, and increasing emphasis on biological therapies and personalized medicine.
According to the MMR report, The Union Budget 2022-23 of India allocated USD 88,700 to the Ministry of Health and Family Welfare, a nearly 18.5 percent increase in comparison to 2020-21.
Johnson & Johnson is an American company that offers a wide range of skincare products and an experimental drug that treats autoimmune disorders. Additionally, Momenta Pharmaceuticals, which created nipocalimab, an anti-FcRn antibody for the treatment of autoimmune diseases, was acquired by J&J. With these new therapies J&J has the potential to earn $5 billion each in peak annual sales.
The Interested Stakeholders can Enquire for the Purchase of the Report : https://www.maximizemarketresearch.com/inquiry-before-buying/198275/
Eli Lilly and Company, an American company pharmaceutical company, has operations in 18 nations and sells its goods in about 125 nations. The company had a market valuation of US$659.746 billion and reported revenue of US$27.50 billion in 2023. Eli Lilly and Company is listed on the New York Stock Exchange under the ticker symbol LLY.
The key driving factors for the Autoimmune Treatment Market are:
• Rapid rise in patient population.
• Increased awareness about autoimmune disease.
Autoimmune Treatment Market segmentation:
by Indication
• Rheumatic Disease
• Diabetes
• Multiple Sclerosis
• Inflammatory Bowel Disease
• Other Indications
by Drug Class
• Anti-Inflammatory
• Anti-Hyperglycemics
• NSAIDs
• Interferons
• Other Drugs
by Product
• Diagnostic Equipment
• Drugs
• Therapeutic & Monitoring Equipment
by Treatment
• Drugs
• Physical Therapy
by Distribution Channel
• Hospitals & Clinics
• Diagnostic Centers
• Drug Stores
• Pharmacies
• Others
Request Sample Copy of this Report @ https://www.maximizemarketresearch.com/request-sample/198275/
Autoimmune Treatment Market Key Players are:
1. AbbVie
2. johnson&Johnson
3. Eli Lilly and Company
4. AstraZeneca
5. Lupin
6. Amgen
7. Bristol-Myers Squibb
8. Pfizer Inc.
9. GlaxoSmithKline
10. Sanofi
11. UCB S.A.
12. F. Hoffmann-La Roche
13. Novartis International AG
14. Merck & Co., Inc
15. Gilead Sciences.
𝐅𝐨𝐫 𝐚 𝐝𝐞𝐞𝐩𝐞𝐫 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤: https://www.maximizemarketresearch.com/market-report/autoimmune-treatment-market/198275/
Key questions answered in Autoimmune Treatment Market are:
1] What segments are covered in the Global Autoimmune Treatment Market report?
2] Which region is expected to hold the highest share in the Global Autoimmune Treatment Market?
3] What was the market size of the Global Autoimmune Treatment Market by 2023?
4] What is the forecast period for the Global Autoimmune Treatment Market?
5] What is the market size of the Global Autoimmune Treatment Market in 2029?
Key Offerings:
Past Market Size and Competitive Landscape (2018 to 2023)
Past Pricing and price curve by region (2018 to 2023)
Market Size, Share, Size & Forecast by Different Segment | 2024-2030
Market Dynamics - Growth Drivers, Regional analysis, Segment Analysis, Competitive landscape
Market Segmentation - A detailed analysis of the Offerings, Vertical, Application and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Maximize Market Research has also published reports related to Autoimmune Treatment Market are:
• Bulgaria Epilepsy Treatment Market size was valued at USD 2475.39 Thousands in 2023 and the total Bulgaria Epilepsy Treatment Market revenue is expected to grow at a CAGR of 2.06 % from 2024 to 2030, reaching nearly USD 2855.17 Thousands.
https://www.maximizemarketresearch.com/market-report/bulgaria-epilepsy-treatment-market/252637/
• Vertigo Treatment Market size was valued at USD 1.68 Billion in 2023 and the total Vertigo Treatment revenue is expected to grow at a CAGR of 4.63% from 2024 to 2030, reaching nearly USD 2.31 Billion by 2030.
https://www.maximizemarketresearch.com/market-report/vertigo-treatment-market/249634/
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoimmune Treatment Market size is expected to grow at a CAGR of 6.9% from 2024 to 2030, reaching nearly USD 9771.2 million by 2030 as per Maximize Market Research. here
News-ID: 3621083 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD

Ultrafiltered Milk Market Valued at USD 8.36 Billion in 2024, Anticipated to Gro …
The Ultrafiltered Milk Market size was valued at USD 8.36 Billion in 2024 and the total Ultrafiltered Milk revenue is expected to grow at a CAGR of 4.6% from 2025 to 2032, reaching nearly USD 11.99 Billion.
Ultrafiltered Milk Market Overview:
Ultrafiltered milk is gaining increasing attention in the dairy and functional food sectors thanks to its enhanced nutritional profile. Through a specialized membrane filtration process, ultrafiltration concentrates higher-molecular weight components…

Bath Towel Market to Grow from USD 10.46 Billion by 2032 at a CAGR of 6.7 %
The Bath Towel Market size reached USD 6.23 Bn in 2024 and is expected to reach USD 10.46 Bn by 2032, growing at a CAGR of 6.7 % during the forecast period.
Bath Towel Market Overview:
The bath towel industry is witnessing steady expansion, fueled by consumers' increasing focus on hygiene, comfort, and home aesthetics. High demand for plush, absorbent towels made of luxury materials such as Egyptian cotton, Turkish cotton,…

Carob Market to Reach USD 374.76 Million by 2032 Growing at a 5.3% CAGR
The global Carob Market was valued at USD 247.92 million in 2024 and is projected to reach USD 374.76 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2025 to 2032.
Carob Market Overview:
The carob market is experiencing significant growth, driven by its increasing popularity as a natural sweetener and plant-based alternative to chocolate. Derived from the seed pods of the carob…

Welding Electrode Market Expected To Reach USD 11.27 Bn by 2032
The Welding Electrode Market size was valued at USD 5.70 Billion in 2024 and the total Welding Electrode revenue is expected to grow at a CAGR of 8.9 % from 2025 to 2032, reaching nearly USD 11.27 Billion.
Welding Electrode Market Overview:
The Welding Electrode Market is evolving as a critical segment within the global manufacturing and construction industries. Welding electrodes are essential consumables that enable reliable and efficient joining of…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…